Cargando…
Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
VitB5 level becomes limiting in sarcomas. It is regulated by the pantetheinase activity of VNN1. VNN1 expression in sarcomas is associated with better prognosis and immune infiltration. In mice, complementation with pantethine, a vitB5 precursor, boosts antitumor immunity.
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690990/ https://www.ncbi.nlm.nih.gov/pubmed/38030222 http://dx.doi.org/10.26508/lsa.202302479 |
_version_ | 1785152643257073664 |
---|---|
author | Miallot, Richard Millet, Virginie Roger, Anais Fenouil, Romain Tardivel, Catherine Martin, Jean-Charles Tranchida, Fabrice Shintu, Laetitia Berchard, Paul Sousa Lanza, Juliane Malissen, Bernard Henri, Sandrine Ugolini, Sophie Dutour, Aurélie Finetti, Pascal Bertucci, François Blay, Jean-Yves Galland, Franck Naquet, Philippe |
author_facet | Miallot, Richard Millet, Virginie Roger, Anais Fenouil, Romain Tardivel, Catherine Martin, Jean-Charles Tranchida, Fabrice Shintu, Laetitia Berchard, Paul Sousa Lanza, Juliane Malissen, Bernard Henri, Sandrine Ugolini, Sophie Dutour, Aurélie Finetti, Pascal Bertucci, François Blay, Jean-Yves Galland, Franck Naquet, Philippe |
author_sort | Miallot, Richard |
collection | PubMed |
description | VitB5 level becomes limiting in sarcomas. It is regulated by the pantetheinase activity of VNN1. VNN1 expression in sarcomas is associated with better prognosis and immune infiltration. In mice, complementation with pantethine, a vitB5 precursor, boosts antitumor immunity. |
format | Online Article Text |
id | pubmed-10690990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-106909902023-12-02 Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma Miallot, Richard Millet, Virginie Roger, Anais Fenouil, Romain Tardivel, Catherine Martin, Jean-Charles Tranchida, Fabrice Shintu, Laetitia Berchard, Paul Sousa Lanza, Juliane Malissen, Bernard Henri, Sandrine Ugolini, Sophie Dutour, Aurélie Finetti, Pascal Bertucci, François Blay, Jean-Yves Galland, Franck Naquet, Philippe Life Sci Alliance Corrections VitB5 level becomes limiting in sarcomas. It is regulated by the pantetheinase activity of VNN1. VNN1 expression in sarcomas is associated with better prognosis and immune infiltration. In mice, complementation with pantethine, a vitB5 precursor, boosts antitumor immunity. Life Science Alliance LLC 2023-11-29 /pmc/articles/PMC10690990/ /pubmed/38030222 http://dx.doi.org/10.26508/lsa.202302479 Text en © 2023 Miallot et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Corrections Miallot, Richard Millet, Virginie Roger, Anais Fenouil, Romain Tardivel, Catherine Martin, Jean-Charles Tranchida, Fabrice Shintu, Laetitia Berchard, Paul Sousa Lanza, Juliane Malissen, Bernard Henri, Sandrine Ugolini, Sophie Dutour, Aurélie Finetti, Pascal Bertucci, François Blay, Jean-Yves Galland, Franck Naquet, Philippe Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title | Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title_full | Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title_fullStr | Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title_full_unstemmed | Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title_short | Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma |
title_sort | correction: the coenzyme a precursor pantethine enhances antitumor immunity in sarcoma |
topic | Corrections |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690990/ https://www.ncbi.nlm.nih.gov/pubmed/38030222 http://dx.doi.org/10.26508/lsa.202302479 |
work_keys_str_mv | AT miallotrichard correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT milletvirginie correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT rogeranais correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT fenouilromain correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT tardivelcatherine correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT martinjeancharles correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT tranchidafabrice correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT shintulaetitia correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT berchardpaul correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT sousalanzajuliane correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT malissenbernard correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT henrisandrine correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT ugolinisophie correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT dutouraurelie correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT finettipascal correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT bertuccifrancois correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT blayjeanyves correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT gallandfranck correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma AT naquetphilippe correctionthecoenzymeaprecursorpantethineenhancesantitumorimmunityinsarcoma |